122 related articles for article (PubMed ID: 14508278)
1. Skeletal muscle uptake detected on FDG PET 48 hours after exertion.
Gradinscak DJ; Fulham MJ; Mohamed A; Constable CJ
Clin Nucl Med; 2003 Oct; 28(10):840-1. PubMed ID: 14508278
[No Abstract] [Full Text] [Related]
2. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
Broski SM; Bou-Assaly W; Gross MD; Fig LM
Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
[TBL] [Abstract][Full Text] [Related]
3. Physiologic 18F-FDG uptake in the serratus anterior muscle: a potential false-positive on PET resolved with PET/CT.
Branstetter BF
AJR Am J Roentgenol; 2006 Aug; 187(2):W235. PubMed ID: 16861520
[No Abstract] [Full Text] [Related]
4. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
5. Extensive skeletal muscle uptake of 18F-FDG: relation to immunosuppressants?
Groves AM; Cheow HK; Win T; Balan KK
J Nucl Med Technol; 2004 Dec; 32(4):206-8. PubMed ID: 15576342
[TBL] [Abstract][Full Text] [Related]
6. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
[TBL] [Abstract][Full Text] [Related]
9. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
10. Elevated F-18 FDG uptake in skeletal muscle.
Yasuda S; Ide M; Takagi S; Shohtsu A
Clin Nucl Med; 1998 Feb; 23(2):111-2. PubMed ID: 9481504
[No Abstract] [Full Text] [Related]
11. [Muscle uptake of 18FDG in positron emission tomography].
Ortega F; Carreras JL; Maldonado A; Pérez-Castejón MJ; Montz R; Gorospe E; Ruiz JA; Nieto C
Rev Esp Med Nucl; 1998; 17(2):120-1. PubMed ID: 9611283
[No Abstract] [Full Text] [Related]
12. Muscle uptake of 18-fluorine fluorodeoxyglucose.
Bar-Shalom R
Semin Nucl Med; 2000 Oct; 30(4):306-9. PubMed ID: 11105931
[No Abstract] [Full Text] [Related]
13. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
14. [Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy].
Lorenzen J; de Wit M; Buchert R; Igel B; Bohuslavizki KH
Nuklearmedizin; 1999; 38(8):333-6. PubMed ID: 10615668
[TBL] [Abstract][Full Text] [Related]
15. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region.
Hany TF; Gharehpapagh E; Kamel EM; Buck A; Himms-Hagen J; von Schulthess GK
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1393-8. PubMed ID: 12271425
[TBL] [Abstract][Full Text] [Related]
16. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
17. Pelvic anatomic localization using ureteral activity on FDG positron emission tomography.
Lin EC; Siegal J
Clin Nucl Med; 2003 Oct; 28(10):836-7. PubMed ID: 14508276
[No Abstract] [Full Text] [Related]
18. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE; Williams KV; Price JC; Goodpaster B
J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
[TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
Nguyen JD; Carrasquillo JA; Little RF; Ryan QC; Wilson W; Chen CC
Clin Nucl Med; 2003 Dec; 28(12):979-80. PubMed ID: 14663321
[No Abstract] [Full Text] [Related]
20. Skeletal muscle hydatid disease with intense 18F-FDG uptake.
Demir MK; Ofluoğlu O
QJM; 2019 Jul; 112(7):523-524. PubMed ID: 30977821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
